CNMD logo

CONMED CORP

CNMDNYSE
๐Ÿ† #1848 by market capEarnings Nov 3 ยท PostUS Equity
$615.55โ–ฒ $29.85 (+4.85%)
Simulated price
1hโ€”
24hโ–ฒ 4.8%
7dโ€”
14dโ€”
30dโ€”
1yโ€”
๐ŸฆMarket Cap
$1.48B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+5.2%
Slowing
๐Ÿ“ŠGross Margin
54.8%
Healthy
๐Ÿ’ตFCF Margin
9.8%
Moderate
โš–๏ธP/S Ratio
1.1x
Cheap
Otter Score
62
Fair
๐Ÿ“Š

Analyst Ratings

Price
$615.55
Total
21
Raised
1
Lowered
6
Avg PT
$37.50
H / L
$39 / $36
InstitutionActionRatingDate
Piper Sandler
ReiteratedNeutral2026-07-30
Wells Fargo
ReiteratedEqual Weight2026-07-30
B of A Securities
DowngradedNeutral โ†’ Underperform2026-06-29
JP Morgan
ReiteratedNeutral2026-04-30
Needham
ReiteratedHold2026-01-29
Stifel
DowngradedBuy โ†’ Hold2025-04-28
Keybanc
ReiteratedOverweight2023-07-27
CL King
ReiteratedBuy2023-05-22
Jefferies
ReiteratedHold2022-10-12
UBS
ReiteratedBuy2021-07-15
Barclays
ReiteratedOverweight2021-05-25
SVB Leerink
ReiteratedMarket Perform2020-07-30
Stifel Nicolaus
ReiteratedBuy2019-10-31
Piper Jaffray
UpgradedNeutral โ†’ Overweight2019-08-22
Ladenburg Thalmann
DowngradedBuy โ†’ Neutral2017-04-27
Leerink Swann
DowngradedOutperform โ†’ Market Perform2016-07-28
Northland Securities
DowngradedOutperform โ†’ Market Perform2015-07-22
Northland Capital Markets
DowngradedOutperform โ†’ Market Perform2015-07-22
Deutsche Bank
ReiteratedBuy2015-05-04
PiperJaffray
ReiteratedNeutral2015-04-23
KeyBanc
ReiteratedSector Weight โ†’ Equal Weight2015-03-16
One row per institution, most recent rating